Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study

医学 (+)-纳洛酮 药店 协议(科学) 立法 家庭医学 机构审查委员会 医疗急救 类阿片 精神科 替代医学 法学 政治学 受体 病理 内科学
作者
Ana L. Hincapie,Michael Hegener,Pamela C. Heaton,Gabrielle Fish,Kathryn Fetters,Gregory T. Sneed,Kathleen Koechlin,Jolene DeFiore-Hyrmer,Amy Holthusen,Neil J. MacKinnon
出处
期刊:Journal of Addiction Medicine [Lippincott Williams & Wilkins]
卷期号:15 (1): 40-48 被引量:10
标识
DOI:10.1097/adm.0000000000000672
摘要

Objectives: In 2015, the State of Ohio passed legislation to allow pharmacists to dispense naloxone under a physician-approved protocol. The legislation allows all individuals authorized under a physician-approved protocol to personally furnish naloxone without requiring clients to be seen by a licensed prescriber, thus expanding the capacity of Ohio's community distribution programs. We aimed to evaluate the implementation of legislation allowing for a physician-approved protocol in pharmacies and other naloxone distribution sites in Ohio, and to compare barriers and facilitators of implementing the law changes among sites that implemented a physician-approved protocol versus sites that did not. Methods: The study used a convergent parallel mixed-method design. Random samples from all pharmacies registered with the State of Ohio Board of Pharmacy and community naloxone distribution sites were selected. Quantitative data were collected via survey (n = 168) and qualitative data were collected via semi-structured interviews (n = 17). Results: Most survey respondents agreed that the policy has expanded access to naloxone at their site for individuals who want or need the medication. Both pharmacies and other naloxone distribution sites identified that leadership and organizational support facilitated protocol implementation and cost, stigma, and lack of naloxone demand challenged protocol implementation. Conclusions: The study identified barriers and facilitators to the implementation of a physician-approved protocol within Ohio. The majority of respondents stated they could implement a protocol. However, barriers of cost, lack of public awareness of naloxone availability, and stigma remain for pharmacies and other naloxone distribution sites.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
瘦瘦的寒珊完成签到,获得积分10
1秒前
冷傲的夜白完成签到,获得积分10
1秒前
2秒前
yi应助fxinglong采纳,获得10
2秒前
3秒前
3秒前
飞行模式完成签到,获得积分10
3秒前
研友_VZG7GZ应助科研通管家采纳,获得10
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
粗犷的语堂完成签到,获得积分10
4秒前
Owen应助科研通管家采纳,获得30
4秒前
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
molihuakai应助科研通管家采纳,获得10
5秒前
嘿嘿完成签到,获得积分10
5秒前
渡人舟应助科研通管家采纳,获得10
5秒前
123应助科研通管家采纳,获得10
5秒前
领导范儿应助科研通管家采纳,获得30
5秒前
molihuakai应助like采纳,获得10
5秒前
慕青应助科研通管家采纳,获得10
5秒前
上官若男应助科研通管家采纳,获得10
5秒前
11发布了新的文献求助10
6秒前
所所应助科研通管家采纳,获得10
6秒前
6秒前
故意的若血完成签到,获得积分20
6秒前
6秒前
6秒前
puppet仔发布了新的文献求助10
7秒前
7秒前
妮妮完成签到,获得积分10
8秒前
经青寒发布了新的文献求助10
8秒前
李昊发布了新的文献求助10
8秒前
星辰大海应助知来者采纳,获得10
9秒前
RED发布了新的文献求助10
9秒前
林玖再发布了新的文献求助10
11秒前
11秒前
点点发布了新的文献求助10
11秒前
刘帅帅发布了新的文献求助10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
化工安全与环保 1000
Autoparametric Resonance in Mechanical Systems 1000
基于锂离子电池正极材料回收的绿色溶剂开发及工程化应用研究 800
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 600
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7656033
求助须知:如何正确求助?哪些是违规求助? 9226740
关于积分的说明 19826594
捐赠科研通 7222254
什么是DOI,文献DOI怎么找? 3280142
关于科研通互助平台的介绍 2440430
邀请新用户注册赠送积分活动 2279741